The relationship of endometrial pathologies with endometrial thickness and inflammatory markers in breast cancers using tamoxifen.
Esma SariogluFisun VuralAyşe Deniz Ertürk CoşkunPublished in: Archives of gynecology and obstetrics (2022)
PDW and RDW may be promising markers for pathological endometrium differentiation, but these preliminary findings should be validated by clinical studies. Measurement of endometrial thickness in asymptomatic patients may predict high-risk women with pathological endometrium in postmenopausal women. Further studies are needed in premenopausal women and those using tamoxifen for more than 5 years.
Keyphrases
- postmenopausal women
- bone mineral density
- endometrial cancer
- end stage renal disease
- ejection fraction
- optical coherence tomography
- newly diagnosed
- breast cancer cells
- prognostic factors
- positive breast cancer
- type diabetes
- pregnancy outcomes
- pregnant women
- young adults
- insulin resistance
- early breast cancer
- childhood cancer